Skip Navigation

An Open-Label Randomized Phase II Trial of SAR439859, Versus Endocrine Monotherapy as Per Physician?s Choice in Patients with Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer with Prior Exposure to Hormonal Therapies AMEERA 3

Brief Summary

Breast Cancer

Study Type:

II Identifier:

Study #:

Start Date:
Mar 18, 2020

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT04059484

View Complete Trial Details & Eligibility at